This study intends to explore whether, or to what extent, the estimated
remnant-like particle cholesterol was associated with coronary collateralization in patients with chronic total occlusion lesions.
METHODS: 792 patients with at least one coronary chronic total occlusion lesion were enrolled. Serum level of
lipid profiles were determined and the estimated
remnant-like particle cholesterol was calculated. The development of coronary collateralization was graded as low (Rentrop score 0-1) or high (Rentrop score 2-3) collateralization according to the Rentrop classification system and then the association between the estimated
remnant-like particle cholesterol and collateralization was assessed.
RESULTS: 222 participants were classified into low collateralization group. The estimated
remnant-like particle cholesterol level was significantly higher in low collateralization (P < 0.001) and
type 2 diabetes mellitus (P = 0.009) group. To further explore the association between the estimated
remnant-like particle cholesterol and the development of coronary collateralization, these patients were divided into 3 groups based on the estimated
remnant-like particle cholesterol tertiles. The prevalence of low collateralization increased stepwise with the tertile groups (T1 12.5% vs. 27.1% vs. 45.3%, P < 0.001). Multivariate logistic regression analysis showed that the estimated
remnant-like particle cholesterol was independently associated with the under-developed collateralization, with an OR and 95%CI of 2.34 (1.46-3.74) and 4.91 (3.01-8.02) in the T2 and T3 group, respectively. The following receiver-operating characteristic analysis indicated that the diagnostic value of estimated
remnant-like particle cholesterol for the low collateralization was 0.696, with a cut-off value of 0.485, and its sensitivity was 82.88%. Besides, the addition of the estimated
remnant-like particle cholesterol into the baseline model consisting of traditional risk factors could improve the incremental value of the discrimination of impaired collateralization only in overall and
type 2 diabetes mellitus populations.
CONCLUSIONS: